AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong drug supply and dedicated manufacturing facility Since launch, Ferring created REBYOTA ...

Therefore, new therapeutic or strategies already available for treatment of CDI have two goals: eradicating the infection, despite the continuation of concomitant therapy, and reducing the ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

"It is not a ‘quad-demic,’ per se, just a lot of respiratory viruses and bacteria at once," he said ... emergency department visits tied to these infections. "From cough to nasal congestion ...

The problem is that infections they cause must be treated with special antibiotics from the "reserve" list. But the more often doctors prescribe these, the quicker bacteria adapt, making those ...

Fungal infections, such as athlete’s foot and ringworm, occur when one type of fungal microbe becomes too prevalent in one area of the body so that the immune system cannot defeat it.

People often make mistakes in differentiating between viral fever and fever caused by bacterial infection. Due to cold weather, changing seasons, and weak immunity, adults and children can fall ...

The high prevalence of these bacterial infections and overuse of antibiotics have contributed to the evolution of drug-resistant bacteria. This makes these infections difficult to treat. The formation ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...